UK healthcare cost agency rejects J&J's nasal spray for depression

UK healthcare cost agency rejects J&J's nasal spray for depression
Britain's healthcare cost agency on Tuesday recommended against including Johnson & Johnson's nasal spray for depression, Spravato, in the country's healthcare network, citing uncertainties over its clinical and cost effectiveness.

from Reuters: Money News https://ift.tt/2GpvafY

via Blogger https://ift.tt/2GrD9sR
January 28, 2020 at 06:06AM